Identification of Bladder Diverticular Stone on 99mTc-Methyl Diphosphonate Bone Scintigraphy and SPECT/CT

Dania G. Malik; Robert G. Ferrigni; Ming Yang

doi:10.2967/jnmt.120.245175

Identification of Bladder Diverticular Stone on ^99mTc-Methyl Diphosphonate Bone Scintigraphy and SPECT/CT

Dania G. Malik, Robert G. Ferrigni, Ming Yang

Research output: Contribution to journal › Article › peer-review

Abstract

We report a bladder diverticular stone with increased 99mTc-methyl diphosphonate uptake on bone scintigraphy and SPECT/CT. Diverticular stone is a known risk factor for bladder malignancy. The deposition of 99mTc-methyl diphosphonate on the crystal surface of the diverticular stone is a rare phenomenon but of clinical significance. Cystolitholapaxy is indicated to remove the diverticular stone and to reduce the risk of bladder cancer.

Original language	English (US)
Pages (from-to)	384-385
Number of pages	2
Journal	Journal of nuclear medicine technology
Volume	48
Issue number	4
DOIs	https://doi.org/10.2967/jnmt.120.245175
State	Published - Dec 1 2020

Keywords

99mTc-MDP
SPECT/CT
bone scintigraphy
diverticular stone

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging

Access to Document

10.2967/jnmt.120.245175

Cite this

@article{08c616b2a5664ba69b54acdfc8243019,

title = "Identification of Bladder Diverticular Stone on 99mTc-Methyl Diphosphonate Bone Scintigraphy and SPECT/CT",

abstract = "We report a bladder diverticular stone with increased 99mTc-methyl diphosphonate uptake on bone scintigraphy and SPECT/CT. Diverticular stone is a known risk factor for bladder malignancy. The deposition of 99mTc-methyl diphosphonate on the crystal surface of the diverticular stone is a rare phenomenon but of clinical significance. Cystolitholapaxy is indicated to remove the diverticular stone and to reduce the risk of bladder cancer.",

keywords = "99mTc-MDP, SPECT/CT, bone scintigraphy, diverticular stone",

author = "Malik, {Dania G.} and Ferrigni, {Robert G.} and Ming Yang",

note = "Publisher Copyright: {\textcopyright} 2020 by the Society of Nuclear Medicine and Molecular Imaging.",

year = "2020",

month = dec,

day = "1",

doi = "10.2967/jnmt.120.245175",

language = "English (US)",

volume = "48",

pages = "384--385",

journal = "Journal of Nuclear Medicine Technology",

issn = "0091-4916",

publisher = "Society of Nuclear Medicine Inc.",

number = "4",

}

TY - JOUR

T1 - Identification of Bladder Diverticular Stone on 99mTc-Methyl Diphosphonate Bone Scintigraphy and SPECT/CT

AU - Malik, Dania G.

AU - Ferrigni, Robert G.

AU - Yang, Ming

PY - 2020/12/1

Y1 - 2020/12/1

N2 - We report a bladder diverticular stone with increased 99mTc-methyl diphosphonate uptake on bone scintigraphy and SPECT/CT. Diverticular stone is a known risk factor for bladder malignancy. The deposition of 99mTc-methyl diphosphonate on the crystal surface of the diverticular stone is a rare phenomenon but of clinical significance. Cystolitholapaxy is indicated to remove the diverticular stone and to reduce the risk of bladder cancer.

AB - We report a bladder diverticular stone with increased 99mTc-methyl diphosphonate uptake on bone scintigraphy and SPECT/CT. Diverticular stone is a known risk factor for bladder malignancy. The deposition of 99mTc-methyl diphosphonate on the crystal surface of the diverticular stone is a rare phenomenon but of clinical significance. Cystolitholapaxy is indicated to remove the diverticular stone and to reduce the risk of bladder cancer.

KW - 99mTc-MDP

KW - SPECT/CT

KW - bone scintigraphy

KW - diverticular stone

UR - http://www.scopus.com/inward/record.url?scp=85097211428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097211428&partnerID=8YFLogxK

U2 - 10.2967/jnmt.120.245175

DO - 10.2967/jnmt.120.245175

M3 - Article

C2 - 32518117

AN - SCOPUS:85097211428

SN - 0091-4916

VL - 48

SP - 384

EP - 385

JO - Journal of Nuclear Medicine Technology

JF - Journal of Nuclear Medicine Technology

IS - 4

ER -